10,000+ stock pitches from top investors available on joinyellowbrick.com
RA CAPITAL MANAGEMENT, L.P. 13F Holdings
Holdings from the most recent 13F from RA CAPITAL MANAGEMENT, L.P.
Filed: 2023-08-14 (Q2 2023) | Holdings: 54 | Value: $5.3B | Filing Link
PREMIUM
Author Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Filing Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Holding Returns | |||||||
|---|---|---|---|---|---|---|---|
| Stock | Put/Call | Change | Holding Pct | Value | Current Return | 3M Return | 1Y Return |
| ASND - ASCENDIS PHARMA A/S | Add 61% ($380.9M) | 18.92% | $1.0B | +91.95% | +0.51% | +50.81% | |
| LEGN - LEGEND BIOTECH CORP | Add 157% ($264.3M) | 8.16% | $432.5M | -50.93% | +1.28% | -13.09% | |
| PCVX - VAXCYTE INC | Add 8% ($30.0M) | 7.44% | $394.1M | -24.40% | +10.36% | +70.41% | |
| DICE - DICE THERAPEUTICS INC | 6.89% | $365.0M | |||||
| ETNB - 89BIO INC | 4.08% | $216.4M | -37.83% | -52.50% | -49.00% | ||
| BIIB - BIOGEN INC | 2.87% | $151.8M | -52.00% | -15.44% | -25.75% | ||
| AVTE - AEROVATE THERAPEUTICS INC | 2.68% | $141.7M | -2.87% | -88.07% | |||
| VRNA - VERONA PHARMA PLC | 2.52% | $133.6M | +369.74% | -21.20% | +49.64% | ||
| CVAC - CUREVAC N V | 2.41% | $127.6M | -50.88% | -39.10% | -64.21% | ||
| TYRA - TYRA BIOSCIENCES INC | 2.33% | $123.2M | -33.97% | -19.69% | +42.83% | ||
| NAMS - NEWAMSTERDAM PHARMA COMPANY | Add 125% ($59.5M) | 2.02% | $107.0M | +78.50% | -8.97% | +49.95% | |
| CTKB - CYTEK BIOSCIENCES INC | Reduce 8% $(9.3M) | 1.98% | $105.0M | -62.56% | -35.99% | -39.35% | |
| JANX - JANUX THERAPEUTICS INC | 1.94% | $102.9M | +98.56% | -29.59% | +232.96% | ||
| GERN - GERON CORP | 1.91% | $101.3M | -46.02% | -32.87% | +54.33% | ||
| INBX - INHIBRX INC | 1.89% | $100.0M | |||||
| RYTM - RHYTHM PHARMACEUTICALS INC | Add 3% ($2.6M) | 1.77% | $93.6M | +149.08% | +20.70% | +75.76% | |
| DAWN - DAY ONE BIOPHARMACEUTICALS I | Add 11% ($9.2M) | 1.76% | $93.2M | -48.44% | -10.46% | +5.56% | |
| RXST - RXSIGHT INC | 1.66% | $87.9M | -49.66% | -7.32% | +71.19% | ||
| COGT - COGENT COMMUNICATIONS HLDGS | Add 7% ($4.9M) | 1.43% | $76.0M | -50.58% | -36.63% | -28.05% | |
| PEPG - PEPGEN INC | 1.37% | $72.7M | -73.70% | -21.48% | +67.96% | ||
| AXSM - AXSOME THERAPEUTICS INC | New Purchase | 1.36% | $71.9M | +54.36% | -16.01% | +19.42% | |
| RNA - AVIDITY BIOSCIENCES INC | 1.34% | $71.2M | +306.28% | -28.88% | +419.29% | ||
| VOR - VOR BIOPHARMA INC | 1.33% | $70.3M | -92.15% | -37.89% | -68.58% | ||
| GHRS - GH RESEARCH PLC | 1.25% | $66.3M | +13.50% | -29.16% | -10.89% | ||
| WVE - WAVE LIFE SCIENCES LTD | 1.18% | $62.6M | +46.10% | +17.53% | +25.76% | ||
| ACRV - ACRIVON THERAPEUTICS INC | 1.18% | $62.3M | -89.55% | -56.61% | -39.55% | ||
| ICVX - ICOSAVAX INC | 1.12% | $59.2M | +14.67% | ||||
| ITOS - ITEOS THERAPEUTICS INC | 1.10% | $58.5M | -14.17% | -15.09% | +29.93% | ||
| FDMT - 4D MOLECULAR THERAPEUTICS IN | New Purchase | 1.05% | $55.5M | -76.61% | -33.85% | -12.20% | |
| MLYS - MINERALYS THERAPEUTICS INC | 1.02% | $54.2M | +19.33% | -48.20% | -25.44% | ||
| ALPN - ALPINE IMMUNE SCIENCES INC | 0.91% | $48.2M | -9.79% | ||||
| VRDN - VIRIDIAN THERAPEUTICS INC | 0.90% | $47.8M | -28.12% | -19.33% | -24.68% | ||
| ABOS - ACUMEN PHARMACEUTICALS INC | 0.89% | $47.0M | -85.03% | -66.85% | -63.99% | ||
| ACRS - ACLARIS THERAPEUTICS INC | 0.86% | $45.6M | -80.35% | -89.90% | -85.14% | ||
| IMGN - IMMUNOGEN INC | Reduce 89% $(368.4M) | 0.83% | $44.0M | +3.44% | |||
| ELVN - ENLIVEN THERAPEUTICS INC | 0.82% | $43.3M | +29.83% | -33.48% | +44.41% | ||
| FULC - FULCRUM THERAPEUTICS INC | 0.72% | $38.3M | +70.91% | +0.48% | +132.93% | ||
| ELYM - ELIEM THERAPEUTICS INC | 0.70% | $36.8M | -52.12% | -3.09% | +135.14% | ||
| TNYA - TENAYA THERAPEUTICS INC | 0.67% | $35.6M | -86.76% | -55.39% | -26.47% | ||
| ANTX - AN2 THERAPEUTICS INC | 0.61% | $32.1M | -87.00% | +88.06% | -88.06% | ||
| PLRX - PLIANT THERAPEUTICS INC | 0.60% | $31.9M | -91.07% | -24.53% | -31.02% | ||
| EYPT - EYEPOINT PHARMACEUTICALS INC | New Purchase | 0.55% | $29.3M | -41.61% | -52.65% | -41.97% | |
| SPRY - ARS PHARMACEUTICALS INC | 0.38% | $20.2M | +94.78% | -34.35% | +96.23% | ||
| HOWL - WEREWOLF THERAPEUTICS INC | 0.35% | $18.7M | -52.69% | -15.38% | -22.31% | ||
| DSGN - DESIGN THERAPEUTICS INC | 0.35% | $18.7M | +41.34% | -18.02% | +51.59% | ||
| SLDB - SOLID BIOSCIENCES INC | 0.34% | $18.0M | +12.16% | -28.08% | +135.68% | ||
| BDTX - BLACK DIAMOND THERAPEUTICS I | New Purchase | 0.34% | $17.8M | -23.62% | -30.98% | +52.76% | |
| NKTX - NKARTA INC | 0.32% | $17.1M | -7.11% | +25.89% | +154.31% | ||
| CELC - CELCUITY INC | New Purchase | 0.29% | $15.4M | +20.33% | +24.11% | +61.08% | |
| IGMS - IGM BIOSCIENCES INC | New Purchase | 0.16% | $8.7M | -84.97% | -28.48% | +12.36% | |
| BLU - BELLUS HEALTH INC NEW | Reduce 100% | 0.00% | $0.00 | ||||
| CLDX - CELLDEX THERAPEUTICS INC NEW | Reduce 100% | 0.00% | $0.00 | ||||
| HLVX - HILLEVAX INC | Reduce 100% | 0.00% | $0.00 | ||||
| KNTE - KINNATE BIOPHARMA INC | Reduce 100% | 0.00% | $0.00 | ||||
| NSTG - NANOSTRING TECHNOLOGIES | Reduce 100% | 0.00% | $0.00 | ||||
| RCKT - ROCKET PHARMACEUTICALS INC | Reduce 100% | 0.00% | $0.00 | ||||